Business Leadership Series

Engage with successful business leaders who will share innovative ideas and insights into leadership styles and emerging trends.

Fall 2017 Schedule

All Business Leadership Series events will take place in Graham Memorial, Room 039 (Basement Level) from 3:00 – 4:00 pm, unless otherwise noted.

Rick Edmunds

Friday, October 6
3:00 — 4:00 pm

Richard C. Edmunds, III (Rick) is a Principal with PwC Strategy& where he leads the Strategy team within Pharma Life Sciences. He was previously Senior Vice President and Leader of the Global Healthcare Practice at Booz & Company (which became part of PwC). He is also now part of PwC’s Global Pharma & Life Sciences Leadership team. He works primarily with leading pharmaceutical and medical product companies globally and in the U.S. Mr. Edmunds’ primary areas of expertise are in corporate and business unit strategy, product and customer strategies, commercial performance improvement, organization, and mergers and acquisitions. Mr. Edmunds brings business strategy and transformation skills and a solid understanding of the health care and pharmaceutical industries. In his recent corporate strategy assignments, he has addressed the implications of changing U.S. market dynamics on pharmaceutical companies and helped define different break-out alternatives for the various lines of business. On the commercialization side, Mr. Edmunds has conducted a number of different customer strategy development efforts (including payor, physician, and consumer) and broader product strategies ranging from launch to mature/end-of-lifecycle stage. Within the context of health reform, Mr. Edmunds has worked on major cross-industry collaboration efforts that include leading pharmaceutical companies, major national health plans, and PBMs.

Mr. Edmunds has written numerous articles related to the changing pharmaceutical landscape, new commercial approaches, organizing to win, and alternative strategic approaches. Most recently he has been a lead writer for Beyond 2020: Building Strategic Coherence in the New Health Economy published in PharmaExecutive and related articles in Managed Healthcare Executive and Strategy & Business.

Mr. Edmunds joined Booz Allen Hamilton/Booz & Company/Strategy& in 2005 after nearly 13 years at McKinsey & Co., where he worked as part of their Pharma/Medical Product Leadership Group. He holds an MBA from the Darden Graduate School of Business Administration at the University of Virginia, where he received both the Shermet Award and the Faculty Award for Academic Excellence in 1992. He holds a BA in economics from the University of North Carolina.

He was formerly Chairman of the Washington Tennis and Education Foundation, Is Vic Chair for Darden’s Corporate Advisory Board and is an Ex-Officio member of the Board of Trustees.,. He has a wife and two children and lives in Alexandria, Virginia.

Rajiv Maluste

Thursday, October 12
7:00 — 8:00 pm

Dr Rajiv G. Maluste has a doctorate in Economic History from the London School of Economics, a Masters in Public Policy from Princeton University and a MBA from Rutgers University.  Rajiv’s previous professional background has been in capital markets for two decades where he gained rich experiences from working in London, New York and Asia.  He was an Executive Director with Morgan Stanley New York and London where he focused on emerging markets and international capital flows.  Rajiv has also worked as an economist for the US Government’s Department of the Treasury in Washington, working with the IMF.  Rajiv launched his independent consultancy in 2011.  His current academic and consulting portfolio includes several UK universities and Study Abroad Programs in London.

 

Past Speakers

Peter Boneparth, Chair of Audit Committee for the Board, Jet Blue Airways

Audrey Boone Tillman, Esq., Executive VP and General Counsel, Aflac Incorporated

Thomas “Tucker” York, Jr., Global Head of Private Wealth Management, Goldman Sachs

Sallie Krawcheck, CEO and Co-founder, Ellevest

Robbie Huffines, Vice Chairman of Investment Banking, J.P. Morgan